Press release
Biobanking Services Market Set for Steady Growth to USD 81.68 Billion by 2033, Led by North America's 40% Global Market Share | DataM Intelligence
Biobanking Services Market
Market growth is driven by rising demand for personalized medicine, increasing biopharmaceutical research and development, and the expanding adoption of biobanks for clinical trials and diagnostics. Additionally, technological advancements in sample storage, management, and data analytics are further supporting market expansion.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/biobanking-services-market?ram
United States: Key Industry Developments
✅ November 2025: Thermo Fisher Scientific expanded its biobanking services with AI-integrated sample tracking systems at U.S. facilities, enhancing precision medicine research efficiency and compliance with FDA guidelines for biospecimen quality.
✅ October 2025: Mayo Clinic launched a national biobank expansion initiative, partnering with pharmaceutical firms to store diverse genomic samples for cancer and rare disease studies, accelerating drug discovery timelines.
✅ September 2025: Beckman Coulter unveiled automated biobanking workstations in key U.S. labs, focusing on high-throughput processing to support growing demands in personalized therapies and biomarker validation.
Asia Pacific / Japan: Key Industry Developments
✅ November 2025: China-based BGI Genomics opened new biobanking hubs in Shanghai, integrating advanced cryopreservation tech to bolster Asia-Pacific genomic research amid rising chronic disease prevalence.
✅ September 2025: India's National Biobank Network received government funding boosts for automated storage upgrades, enabling better sample access for pharmaceutical trials across the region.
✅ March 2025: The Japanese government initiated a national biobank program, collaborating with universities to create a centralized genomic and biospecimen database for rare disease research and population health studies.
Key Merges and Acquisitions(2025):
✅ Thermo Fisher Scientific - bolstered its biobanking leadership by acquiring advanced automation technologies from a key player in sample management systems, enhancing AI-driven tracking capabilities for global research networks.
✅ Standex International Corporation - expanded its Scientific division through the $6.2 million acquisition of Custom Biogenic Systems in late 2024, integrating cryogenic storage solutions to strengthen presence in pharmaceutical and biobank equipment markets.
✅ BioIVT - grew its U.S. biorepository infrastructure via partnerships and potential acquisitions with oncology centers, improving access to diverse tumor biospecimens for precision medicine applications.
Market Segmentation Analysis:
-By Service Type: Human Tissue Biobanking Leads with Repository Focus
Human Tissue Biobanking holds the largest share at 38.6% as of 2025, driven by high demand in oncology cohort studies and population genomics research requiring preserved tissue samples for advanced diagnostics.
Stem Cell Biobanking supports regenerative therapies by storing pluripotent cells for disease modeling and transplant applications.
DNA/RNA Biobanking enables genomic sequencing and personalized medicine through stable nucleic acid preservation.
Cord Biobanking focuses on umbilical cord blood for hematopoietic stem cell treatments in blood disorders.
Other Services, including lab processing and cold chain logistics, fill gaps in validation and data management.
-By Sample Type: Blood Products Dominate Accessibility
Blood Products lead with around 40% share due to their ease of collection, versatility in serological testing, and widespread use in epidemiological studies.
Human Tissues provide critical insights into disease pathology for drug discovery and tissue engineering.
Cell Lines offer immortalized cultures for reproducible research in cancer and infectious diseases.
Nucleic Acids are essential for molecular biology, enabling PCR, sequencing, and biomarker identification.
-By Application: Clinical Research Drives Expansion
Clinical Research commands the top position at approximately 35% market share, fueled by trial needs for patient stratification and companion diagnostics in pharma pipelines.
Regenerative Medicine leverages biobanks for stem cell therapies targeting organ repair and anti-aging.
Life Science research utilizes samples for basic discovery in genetics and proteomics.
Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=biobanking-services-market?ram (Purchase 2 or more Reports and get 50% Discount)
Growth Drivers:
-Rising prevalence of chronic diseases like cancer, Alzheimer's, and cardiovascular conditions drives demand for high-quality biospecimens in research and drug development.
-Increasing investments in genomic research, precision medicine, and population genomics programs fuel the need for advanced sample storage and analysis.
-Rapid expansion of cell and gene therapy pipelines requires reliable biobanking for clinical trials and personalized treatments.
-Advancements in automation, digital tracking, and virtual biobanking technologies improve efficiency and scalability of operations.
-Growing government and corporate funding for regenerative medicine and biobank infrastructure supports market expansion.
Regional Insights:
-North America leads the biobanking services market with the highest regional share, approximately 40% as of 2025, driven by advanced healthcare infrastructure, substantial R&D investments in genomics and precision medicine, and major biobanks like the NIH Biobank in the US. This dominance stems from high-capacity facilities and key players such as Thermo Fisher Scientific, supporting extensive clinical research and biopharmaceutical development.
-Europe follows as the second-largest market, holding around 30% share in 2025, with strong contributions from countries like Germany (projected at 31.8% of Europe's market), France, and the UK due to pharmaceutical advancements and EU research standardization. Growth is fueled by automation in storage and established research centers in Berlin and Munich.
-Asia Pacific ranks third with an estimated 25% global share, emerging as the fastest-growing region at over 10% CAGR through 2030, propelled by investments in China's National GeneBank, expanding biopharma sectors in India and South Korea, and rising clinical trials. Demographic diversity and government-funded genomics projects further accelerate adoption.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/biobanking-services-market?ram
Key Players:
Thermo Fisher Scientific Inc. | Tecan Trading AG | QIAGEN | Harrow Green Limited | TTP Labtech | UHN Biospecimen Services | VigiSolvo | Sampled | Crown Bioscience Company (Indivumed Services)
Key Highlights (Top 5 Key Players) for Biobanking Services Market:
-Thermo Fisher Scientific Inc. leads with robust biobanking automation solutions, contributing significantly to the sector's growth through sample management systems amid rising demand for precision medicine research.
-Tecan Trading AG reported CHF 439 million in H1 2025 sales, with Life Sciences Business growth supporting biobanking automation tools despite a 3.7% local currency decline.
-QIAGEN drives nucleic acid handling for biobanks, expanding portfolios in sample prep technologies as genomic research accelerates global market expansion.
-UHN Biospecimen Services specializes in high-quality human sample repositories, enabling clinical trials and personalized therapies with scalable storage infrastructure.
-Crown Bioscience Company (Indivumed Services) advances oncology biobanking via integrated services, facilitating drug discovery with annotated patient-derived models.
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biobanking Services Market Set for Steady Growth to USD 81.68 Billion by 2033, Led by North America's 40% Global Market Share | DataM Intelligence here
News-ID: 4306817 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Generic Drugs Market to Reach US$ 942.69 Billion by 2033 at 7.1% CAGR | North Am …
The global generic drugs market reached US$ 508.47 billion in 2024 and is projected to grow to US$ 942.69 billion by 2033, registering a CAGR of 7.1% during the forecast period 2025-2033. Market expansion is driven by rising healthcare costs worldwide, increasing demand for cost-effective treatment options, and the growing number of patent expirations of branded drugs. The surge in chronic disease prevalence and the need for accessible medications in…
United States Cutaneous Squamous Cell Market Growth Forecast to 2031: Key Player …
Cutaneous Squamous Cell Carcinoma Market growing at a CAGR of 7.2 % during the forecast period (2024-2031). latest report release by DataM Intelligence
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/cutaneous-squamous-cell-carcinoma-market?kb
United States: Recent Industry Developments
✅ November 2025: FDA approved a novel PD-1 inhibitor therapy for advanced cutaneous squamous cell carcinoma treatment.
✅ October 2025: Increased adoption of non-invasive imaging technologies improved early diagnosis and…
Rare Disease Therapeutics Market to Reach US$ 495.27 Billion by 2033 at 13.8% CA …
The global rare disease therapeutics market reached US$ 135.88 billion in 2023, increased to US$ 154.64 billion in 2024, and is projected to reach US$ 495.27 billion by 2033, growing at a robust CAGR of 13.8% during 2025-2033. Market expansion is driven by the rising identification of rare genetic and chronic conditions and an increasing focus on precision-based treatment approaches. Progress in molecular diagnostics and genomics is enabling earlier, more…
Agricultural Biologicals Market Set for Robust Growth to USD 13,382.11 Million b …
The Global Agricultural Biologicals Market reached USD 15,456.34 million in 2024 and is expected to reach USD 13,382.11 million by 2032, growing at a robust CAGR of 15.50% during 2025-2032.
Market growth is fueled by the rising shift toward sustainable farming practices, increasing demand for organic food, and the need to reduce chemical pesticide usage. Advancements in bio-stimulants, bio-pesticides, and bio-fertilizers, along with supportive government policies promoting eco-friendly agriculture, are further…
More Releases for Biobank
Global Biobank Market : Trending factors & Growth Drivers Impact Globally
The global biobank market size was USD 76.31 Billion in 2022 and is expected to register a revenue CAGR of 8.8% during the forecast period. The global biobank market is witnessing strong revenue growth, fueled by increasing funding in genomic research, rising demand for personalized medicine, and rapid technological advancements. Biobanks, which store and manage biological samples such as blood, cells, and tissues, play a critical role in therapeutic research,…
US biobank Market Size To Boom with Top Key Players 2032 | Penn Medicine BioBank …
The qualitative latest Research report (2025-2032) on the US biobank Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/135012
Focused on growth and…
Biobank Sample Management And Storage System Market Size Analysis by Application …
USA, New Jersey- According to Market Research Intellect, the global Biobank Sample Management And Storage System market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The growing need for biobanking solutions in the research and healthcare sectors is driving significant expansion in the market for biobank…
Biobanking Market Growth Strategies and Insights, Business Perspectives 2022-202 …
The global biobanking market is poised to grow by USD 18 billion during 2022-2028, progressing at a CAGR of 4.5% during the forecast period.
Biobanking Market 2022 research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state…
Cryopreservation Equipment Market is expected to reach US$ 11,255.02 Mn With CAG …
According to our latest market research study on “Cryopreservation Equipment Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type and Application,” the market is expected to reach US$ 11,255.02 million by 2028 from US$ 5,798.82 million in 2021; it is estimated to grow at a CAGR of 9.9% from 2021 to 2028. The report highlights the market trends, drivers, and deterrents. Growing acceptance for…
Biobank Market || Opportunity and Industry Revenue Analysis
Prophecy Market Insights has recently published the Biobank informational report which will help retailers, manufacturers, and distributors to understand and realize the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue. This Biobank market report states the overview, historical data along with size, share, growth, demand, and revenue of the global industry. The report analyses the attractive opportunities…
